The global In vitro fertilization market is projected to be valued at USD 505.2 Million in 2017 and is expected to grow at a CAGR of 10.9% to reach to USD 847.8 Million by 2022.
Seattle, WA -- (SBWIRE) -- 10/13/2017 -- The report "In Vitro Fertilization Market by Product (Imaging System, Incubator, Cabinets, Sperm Separation System, Cryopreservation media, Embryo Culture media), Type of Cycles & End Users (Fertility Clinics and Surgical Centres, Cryobanks) - Global Forecast to 2022", The global In vitro fertilization market is projected to be valued at USD 505.2 Million in 2017 and is expected to grow at a CAGR of 10.9% to reach to USD 847.8 Million by 2022. The key factors propelling the growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options.
Browse 106 Market Data Tables and 33 Figures spread through 181 Pages and in-depth TOC on "In Vitro Fertilization Market"
Early buyers will receive 10% customization on reports.
Reagents to account for the largest product segment in the IVF market in 2017
The product segment is classified into reagents and equipment. Reagents are further classified into cryopreservation media, semen processing media, ovum processing media, and embryo culture media. Embryo culture media is expected to hold the largest share of the IVF reagents market in 2017. This segment is also expected to grow at the highest rate during the forecast period owing to the increase in awareness of infertility treatments and diagnosis. Moreover, this media is used in IVF procedures to improve the quality of embryos during the developing phase.
Fertility clinics and surgical centers to dominate the IVF market during the forecast period
By end user, the in vitro fertilization market is segmented into fertility clinics and surgical centers, hospitals and research laboratories, and cryobanks. Fertility clinics and surgical centers are estimated to account for the largest share of the global IVF market. The increasing number of fertility centers coupled with the growing infertility rates across the globe are the key factors driving the growth of this segment.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=89198891
The fresh non-donor cycle to hold the largest market share in 2017
On the basis of types of cycles, the IVF market is classified into fresh non-donor, frozen non-donor, fresh donor, and frozen donor cycles. The fresh non-donor cycle is estimated to account for the largest market share of the market in 2017. Factors such as high success rates, ease in the implantation process, and enhanced embryo production are responsible for the large share of this segment.
Asia Pacific dominated the market in 2017
Asia Pacific is expected to dominate the global in vitro fertilization market in 2017. The large share and high growth rate of the APAC region can be attributed growth in the median age of first-time motherhood, rising infertility rates, growing prevalence of PCOS, increasing incidence of obesity, rise in fertility tourism, and government initiatives.
CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US) are the major players in the in vitro fertilization market. Other players include Esco Micro (Singapore), IVFtech (Denmark), EMD Sereno (US), Genea Limited (Australia), Rocket Medical (UK), and Nidacon International (Sweden).
Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States